Use of Autologous Platelets for Lamellar Macular Hole Repair

Table 1

Patient characteristics.

Patient	1	2	3
Age (Gender)	70 (Female)	74 (Male)	72 (Female)
Lens status	Pseudophakic	Pseudophakic	Pseudophakic
Preoperative CMT (µm)	199	83	134
1-month CMT (µm)	230
3-month CMT (µm)
6-month CMT (µm)	250	228	212
Pre-treatment Snellen VA; (logMAR)	20/40 (sc); 0.30	20/400 (sc) (NI PH); 1.3	20/80 (sc); 0.60
1-month Snellen VA; (logMAR)	20/60 (sc); 0.48	20/200 (sc) (NI PH); 1	20/100 (sc); 0.70
3-month Snellen VA; (logMAR)		20/50 (BCVA); 0.40	20/100 (sc); 0.70
6-month Snellen VA; (logMAR)	20/30 (sc); 0.18	20/70 (BCVA); 0.54	20/60 (sc); 0.48
Observation Period (months)	6	12	6

cc: with correction; sc: without correction.